$1.5m funding for breast cancer project:
This article was originally published in Clinica
An investigation into new ways to detect breast cancer is underway with joint funding of $1.5 million from Hyal Pharmaceutical and the Natural Sciences and Engineering Research Council of Canada. Researchers at McMaster University, the University of Toronto and the Toronto Hospital, will attempt to find out if hyaluronic acid used with MRI in mammography will result in more reliable detection of early-stage breast cancer. Hyaluronic acid binds to breast cancer cells and will be used as a carrier for MRI imaging agents.
You may also be interested in...
No device-related warning letters were released by the US FDA the week of 31 March.
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
COVID-19: Medtronic Shares Ventilator Specs Amid Multi-Industry Efforts To Increase Ventilator Production
Medtronic shares an open-source design for its ventilator to help mitigate the nation’s ventilator shortage for COVID-19 patients.